Author

Azucena Salas 1

1 Hospital Clínic Villarroel

A COMPREHENSIVE MOLECULAR CLASSIFICATION OF CROHN'S DISEASE USING GENE EXPRESSION DATA

Kevin Perez, Lionel Le Bourhis, Marjolaine Ngollo, Julian Panés, Azucena Salas, Philippe Seksik, Dirk Haller, Mark J. Daly, Matthieu Allez

Biomarkers in IBD as a guide to clinical management

Azucena Salas

DIET CONTROLS SEGMENTED FILAMENTOUS BACTERIA IN DRIVING CROHN’S DISEASE-LIKE ILEO-COLONIC INFLAMMATION IN TNFDELTAARE MICE

Amira Metwaly, Jelena Calasan, Nadine Waldschmitt, Sevana Khaloian, Deborah Püngel, Mohamed Ahmed, Nassim Hammoudi, Lionel Le Bourhis, Ludovica F. Butto, Aida Mayorgas, Kolja Siebert, Marijana Basic, Sebastian Zeissig, Tobias Schwerd, Julian Panés, Azucena Salas, Matthieu Allez, André Bleich, Fabio Cominelli, Dirk Haller

IL-1 family of cytokines in intestinal inflammation

Azucena Salas

INTEGRATED MICROBIOTA AND METABOLITE PROFILES IN HUMAN AND MICE IDENTIFIED FUNCTIONAL SIGNATURES IN CROHN'S DISEASE WITH A LINK TO SULFATE METABOLISM

Amira Metwaly, Andreas Dunkel, Nadine Waldschmitt, Ludovica Buttό, Ilias Lagkouvardos, Ana Maria Corraliza, Aida Mayorgas, Sinah Schmidt, Abilash Chakravarthy Durai Raj, Michael Schloter, Thomas Hofmann, Julian Panés, Azucena Salas, Dirk Haller

INTRINSIC DEFECTS IN THE EPITHELIAL STEM CELL COMPARTMENT COULD CONTRIBUTE TO THE PERPETUATION OF ULCERATIVE COLITIS

Isabella Dotti, Elena Ferrer, Nuria Planell, Rut Mora-Buch, M Carme Masamunt, Peter Jung, Eduard Batlle Gomez, Julian Panés, Azucena Salas

MECHANISMS OF NON-RESPONSE TO ADALIMUMAB IN INFLAMMATORY BOWEL DISEASE: PERIPHERAL PROTEOMIC AND TRANSCRIPTOMIC PROFILING FROM THE SERENE-CD AND SERENE-UC STUDIES

Julian Panés, Bram Verstockt, Valerie Pivorunas, James Butler, Naim Mahi, Melanie Ruzek, Thierry Sornasse, James Fann, Feng Hong, Xiaohong Cao, Nizar Smaoui, Justin Wade Davis, Jasmina Kalabic, Alexandra Song, Heath M. Guay, Azucena Salas, Nick Kennedy, Tariq Ahmad, Severine Vermeire

Pathopysiological discoveries

Azucena Salas

PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATE TO SEVERELY ACTIVE ULCERATIVE COLITIS

Marna Williams, Mary E. Keir, Caroline Looney, Franklin Fuh, Wei Tew, Kathleen Howell, Sha Klabunde, Clarissa Johnson, Xiaohui Wei, Meina Tang, Diana Luca, Azucena Salas, Severine Vermeire, Clementine Perrier, Julian Panés, Daniel C. Baumgart, John Charles Mansfield, Maren Paulsen, Philip Rosenstiel, Stefan Schreiber, I

PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Caroline Looney, Franklin Fuh, Meina Tang, Xiaohui Wei, Mary E. Keir, Gaik Tew, Jeffrey Eastham-Anderson, Lauri Diehl, Azucena Salas, Gert De Hertogh, Steven Francom, Houston Gilbert, Diana Luca, Jackson Egan, Severine Vermeire, John Charles Mansfield, Christopher Andrew Lamb, Brian G. Feagan, Julian Panés, Daniel C. Bau

Item 1 - 10 / 19
1
2